Regeneron Pharmaceuticals (REGN)
$454.87 8.18 (1.77%)
15:53 EST REGN Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 48.19B
PE Ratio 36.86
Volume (Avg. Vol.) 579,007
Day's Range 454.35 - 466.00
52-Week Range 418.01 - 664.64
Dividend & Yield N/A (N/A)
REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News
- From InvestorPlace
- From the Web
Investors are enamored with high profile stocks and ignoring ones that are solid investments. Here are three biotech stocks to consider.
Ford, Clorox, Regeneron and Luckin Coffee were our top stock trades for Monday. Let's get a look at the charts as we head into next week.
Investing in stocks that show long-term potential is a tried and true way to earn some long-term gains. Here’s a look at seven growth stocks worth buying this year.
Pharmaceutical stocks, such as Moderna and Novavaxsaw their share prices more than double in the last year. However, not all pharmaceutical stocks have their wagons hitched to solving the Covid-19 pandemic. There are many pharmaceutical stocks that are great long-term investments and would be good additions to a portfolio in any environment. Here we look at four such pharmaceutical stocks.
Biden stocks like APT stock, KODK stock, MMM stock and CAH stock are all ones to watch thanks to the Defense Production Act.
Amazon, Plug Power, GameStop and Regeneron were our top stock trades for Thursday. Let's have a look at the charts after some big moves.
Investors already enjoying strong gains in the year may want to look at these short-term stocks to buy heading into the new year.
Now that companies such as Pfizer, Moderna and AstraZeneca have emerged with viable vaccines against Covid-19, the hype around many pharmaceutical stocks is fading. Here are four stocks investors should be weary of in the weeks ahead.
As Pfizer and Moderna take the lead in the novel coronavirus vaccine race, here’s how this affects other Covid-19-related biotech stocks.
REGN stock is shifting the market today thanks to news its coronavirus treatment received emergency FDA approval.
Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives. With them, we can solve Covid-19.
The U.S. government has pulled out all the stops to develop a treatment for Covid-19. These biotech stocks are leading the race for a cure.
Biotech stocks are always going to be here, in good times and bad. Let's look at a few that are worth considering on the long side.
Investors are banking on an upsurge in pharmaceutical stocks once various vaccines and other therapies gain commercial approval from the U.S. Food and Drug Administration (FDA). Here is a list of pharmaceutical companies that stand to benefit in the coming months.
With Trump's support, Regeneron just filed for emergency-use authorization with the FDA. REGN stock is climbing on the news.
As the race to develop a vaccine continues, these biotech stocks could be high risk, high return propositions.
Square, Regeneron, Aphria and Tilray were our top stock trades for Tuesday. That said, here's how the charts look after Monday's action.
Regeneron Pharmaceuticals (REGN) stock is soaring Monday on news that its treatment for the coronavirus was used on President Trump.
A handful of pharmaceutical stocks have been on fire lately, but I'm writing for a "buy" prescription for five of the best names now.
From Market News Video
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Rite Aid Corp (RAD), where a total volume of 19,413 contracts has been traded thus far today, a contract volume which is representative of approximately 1.9 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 81% of RAD's average daily trading volume over the past month, of 2.4 million shares..
From Market News Video
Navellier RatingsPowered by Portfolio Grader